Quick Facts

• Primary Use: Addressing dehydration and electrolyte loss.
• Core Benefit: Serves as a source of water and essential electrolytes.
• Therapeutic Domain: Fluid and electrolyte replacement, particularly in cases of acute fluid imbalance.

---

What Дисоль Treats: Main Uses and Benefits

This medication is primarily indicated for fluid and electrolyte replenishment in patients. It is used in clinical settings as a source of water and electrolytes to help manage conditions associated with volume depletion or imbalance.

The therapeutic goal of this solution is to support the restoration of normal hydration and address deficiencies in essential salts, such as sodium and chloride. This approach helps maintain bodily functions when a patient is unable to receive adequate fluids and electrolytes through typical means.

In addition to correcting acute deficits, the solution may be used to support the maintenance of a stable fluid volume during periods of illness or medical procedures.

The official regulatory criteria for using Дисоль (an intravenous sodium and acetate solution) are defined by the patient's existing fluid, electrolyte, and acid-base status.

Eligibility Scope

Classification	Population or Condition
Contraindicated	Severe hypernatremia (high serum sodium)
	Extracellular fluid overload (overhydration)
	Metabolic or respiratory alkalosis (due to the acetate component)
Restricted/Caution	Severe renal insufficiency or Congestive Heart Failure (CHF)
	Severe hepatic insufficiency (cirrhosis)
	Patients receiving corticosteroids or corticotropin

Age-Group and Physiological Status

Age-related eligibility rules: Use has been established in pediatric patients (infant to adolescent); however, premature neonates are at particular risk of aluminum toxicity with impaired kidney function. Geriatric patients require cautious dose selection, reflecting the greater frequency of decreased organ function.

Pregnancy and lactation eligibility status: The medicine should be given to a pregnant woman only if clearly needed. Caution must be exercised during lactation, as it is not known whether the drug is excreted in human milk.

The eligibility profile is strictly focused on conditions that may be exacerbated by the solution's sodium and volume content, or the acetate component's effect on blood pH. Eligibility is prohibited for groups with high sodium or high pH, and is restricted for those with impaired heart, kidney, or liver function.

Interactions with other medicines and products

The interaction profile of Дисоль (an electrolyte solution containing sodium chloride, potassium chloride, and sodium acetate/bicarbonate) is primarily defined by the risk of cumulative effects on electrolyte and fluid balance when used alongside certain medicinal product classes.

---

Products Affecting Potassium Balance

Co-administration with agents that can increase serum potassium concentration requires close patient monitoring to mitigate the risk of severe hyperkalemia. This includes products such as:

• Potassium-sparing diuretics (e.g., amiloride, spironolactone, triamterene)
• Angiotensin-converting enzyme (ACE) inhibitors
• Angiotensin II receptor blockers (ARBs)

Official regulatory information emphasizes that the combination with these classes constrains use to situations where serum potassium levels can be consistently checked and managed.

---

Products Affecting Sodium and Fluid Balance

Regulatory documents highlight the need for caution when Дисоль is administered concomitantly with medicines that can cause sodium and fluid retention. This interaction is pharmacodynamic, increasing the overall body load of sodium and volume. Such interacting categories include:

• Corticosteroids
• Carbenoxolone

These constraints ensure that the combined effect does not lead to clinically significant complications like fluid overload or exacerbation of existing cardiac or renal conditions.

How Дисоль Works: Mechanism of Action

Leveraging Sodium-Glucose Coupled Transport

Дисоль operates primarily by engaging the SGLT1 co-transporter system in the intestinal lining. This mechanism utilizes the simultaneous absorption of sodium ions ( Na^+) and glucose to actively drive the uptake of water from the gut into the circulation . This action increases the passive diffusion of water into the circulation, which influences intravascular fluid volume and systemic osmotic pressure.

Modulating Electrolyte and Acid-Base Pathways

The solution provides essential electrolytes ( Na^+, Cl^-, K^+) which contributes to maintaining ion gradients across cellular membranes. Additionally, it provides base equivalents (via a bicarbonate precursor) that engage the extracellular buffering system to influence plasma pH. The resulting change in ion concentrations modulates membrane potential and electrochemical gradients, which influences nerve, muscle, and cellular function.

Influence on Systemic Dynamics

By affecting fluid volume and ion concentrations, the mechanism impacts circulatory system dynamics and overall tissue perfusion. This action supports the regulation of various physiological pathways, including those governing cardiac excitation and cellular metabolism.

Official Administration Guidelines

Дисоль is administered as a Solution for infusion and is restricted to the Intravenous (IV) route. Administration requires constant medical supervision, typically in an acute care setting.

Dosing and Administration

Administration Scope	Official Regulatory Rules
Route of Administration	Intravenous (IV) only.
Dosing Schedule	The volume and rate are highly individualized and determined by the patient's age, weight, and continuously monitored fluid, electrolyte, and acid-base status.
Frequency/Timing	Administered as a continuous infusion or rapid bolus as needed to correct acute deficits; the rate must be continuously adjusted based on the clinical response.
Preparation Requirements	The solution must be visually inspected for clarity, particulate matter, and an intact seal before use. Aseptic technique is required for administration.
Age-Group Rules	Older adults require cautious dose selection due to the greater frequency of decreased renal and cardiac function. Pediatric use requires close monitoring of plasma electrolyte concentrations.
Special Conditions	Requires medical supervision for infusion; do not connect flexible containers in series, and check for compatibility before adding other medications.

Procedural Summary

Official instructions establish a strict protocol. The solution must first be inspected for clarity. The specific dose and infusion rate are determined individually to match the patient's deficits. Administration is carried out via a sterile IV line, and the infusion rate must be continuously monitored and adjusted to ensure correction of the fluid imbalance. Use is maintained only as required to restore and sustain the corrected physiological state.

Research Evidence / Overview of Studies for Дисоль

This overview summarizes the available research concerning the use of crystalloid solutions like Дисоль for fluid and electrolyte imbalance. This information describes what has been studied and observed in clinical trials, but it is not intended as medical advice or a prediction of individual outcomes.

---

Evidence for Fluid and Electrolyte Replenishment (General Use)

Research was studied for its role in addressing fluid and electrolyte imbalance in acute clinical contexts. Randomized Controlled Trials (RCTs) and Systematic Reviews have been used in research exploring this goal, particularly by examining balanced crystalloid solutions. Research examined these balanced fluids in trials that also included another common intravenous fluid, 0.9% saline, as a comparator.

Studies monitored outcomes related to systemic or functional imbalance, such as the restoration of fluid volume and the correction of sodium and chloride levels. Findings describe patterns observed regarding electrolyte levels and acid-base balance. However, when looking at major, intermediate-term endpoints like survival, the findings were mixed and inconsistent across the largest available studies.

---

Evidence for Acid-Base Balance and Correction

Solutions containing Sodium Acetate was studied for their relationship to acid-base status (or pH) in research. These trials specifically monitored biochemical outcomes, such as changes in the body's serum bicarbonate levels and the occurrence of elevated chloride levels. Evidence suggests that solutions with components like acetate was associated with different acute shifts in pH and bicarbonate levels in trials that also monitored 0.9% saline. Studies monitored the incidence of hyperchloremia and reported patterns related to the composition of the intravenous fluid administered.

---

What is Still Uncertain About the Research

Research on fluid replacement, including the use of solutions like Дисоль, still has areas that are not fully understood. Data for certain groups remain insufficient, and the evidence quality varies across studies due to differences in design, patient types, and how outcomes were measured. While short-term biochemical changes are described, certainty remains low about how these acute shifts translate into long-term patient outcomes.

Key Studies & References

1. Intravenous Electrolytes (MedlinePlus Encyclopedia)

Common questions about Дисоль (FAQ)

Q: What are the most common side effects of Дисоль?

Official product information indicates that potential adverse effects are primarily linked to the volume and rate of the infusion. Regulatory information suggests that these potential effects include fluid and electrolyte disturbances, such as conditions of excess fluid (hypervolemia) or changes in the body’s salt balance. Reactions at the injection site are also possible, such as vein inflammation (phlebitis) or pain. A comprehensive list of all observed side effects and their frequency is detailed in the official product labeling.

---

Q: Can I get Дисоль if I have kidney or liver problems?

Official regulatory documents advise that caution be exercised for patients with impaired renal (kidney) function due to the potential for toxic reactions and fluid overload. Caution is also advised for patients with severe hepatic (liver) insufficiency, such as cirrhosis. Furthermore, the product is formally restricted (contraindicated) for use in patients with severe kidney insufficiency.

---

Q: Is Дисоль safe for my baby or child?

The official product information indicates that the use of Дисоль is established in pediatric patients (infants and children). However, regulatory documents indicate that close monitoring of plasma electrolyte levels is needed for these patients due to a heightened risk for severe electrolyte disturbances, such as acute hyponatremia (low sodium levels). Additionally, premature newborns are noted in official warnings to be at risk for aluminum toxicity.

How to Store and Dispose of Дисоль

Official regulatory documents define specific requirements for storing and disposing of Дисоль to ensure product stability and environmental safety.

Storage Conditions

Storage Requirement	Official Classification
Temperature	Store at a temperature not exceeding 25°C (some labels specify 2°C to 25°C).
Protection	Store in the original container, in a place inaccessible to children.
Stability Check	Do not use the solution after the expiration date, or if there is a change in color, suspended particles, or sediment.

Disposal Instructions

Unused or expired Дисоль must be disposed of according to local regulatory requirements. It is officially instructed not to pour the product down the drain or discard it with regular household waste. These measures are required to prevent environmental contamination and are mandatory for all patients.